siklos
theravia - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - siklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in paediatric and adult patients suffering from symptomatic sickle-cell syndrome.
hydrea 500mg capsules
neon healthcare ltd - hydroxycarbamide - oral capsule - 500mg
hydroxycarbamide 500mg capsules
medac uk - hydroxycarbamide - oral capsule - 500mg
hydroxycarbamide 500mg capsules
a a h pharmaceuticals ltd - hydroxycarbamide - oral capsule - 500mg
siklos 100mg tablets
nordic pharma ltd - hydroxycarbamide - tablet - 100mg
xromi
nova laboratories ireland limited - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - prevention of vaso-occlusive complications of sickle cell disease in patients over 2 years of age
hydroxycarbamide medac capsules
medac gmbh - hydroxycarbamide - capsules - 500mg
hydroxyurea medac 500 mg
tzamal bio-pharma ltd - hydroxycarbamide - capsules - hydroxycarbamide 500 mg - hydroxycarbamide - treatment of patient with chronic myeloid leukaemia (cml) in the chronic or accelerated phase of the disease.treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.
hydrea 500 mg hard capsules
bristol-myers squibb pharmaceuticals uc - hydroxycarbamide - capsule, hard - 500 milligram(s) - other antineoplastic agents; hydroxycarbamide
hydrea 500 mg hard capsules
cheplapharm arzneimittel gmbh - hydroxycarbamide - capsule, hard - other antineoplastic agents; hydroxycarbamide